Megha Manchanda &Amp; Sohini Das

Stories by Megha Manchanda &Amp; Sohini Das

No cut in spectrum price as govt okays airwave auction

No cut in spectrum price as govt okays airwave auction

Rediff.com   21 Dec 2019

Although the industry is disappointed with the government decision not to lower spectrum prices at a time telcos are saddled with over Rs 4-trillion debt and an estimated Rs 1.43-trillion licence fee dues, the DCC has relaxed the payment structure to offer some relief to the financially stressed sector.

Despite slump, Airtel to go ahead with Rs 20K-cr investment plan

Despite slump, Airtel to go ahead with Rs 20K-cr investment plan

Rediff.com   19 Dec 2019

Mittal said he discussed a plethora of issues with Commerce and Industry Minister Piyush Goyal and sought the government's support for faster clearances to streamline the group's investment plans.

What is the future of e-pharmacies in India?

What is the future of e-pharmacies in India?

Rediff.com   19 Dec 2019

PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.

Delhi is crumbling under its own weight

Delhi is crumbling under its own weight

Rediff.com   18 Dec 2019

While Delhi boasts of one of the best metro systems in the world and decent infrastructure, reckless construction, legalising unauthorised colonies, and the worsening water and air quality dent its image of being a robust cosmopolitan city.

How govt plans to ensure faster availability of new drugs

How govt plans to ensure faster availability of new drugs

Rediff.com   16 Dec 2019

Concerned about the rise of antibiotic resistance and the time it takes for drugs developed abroad to reach Indians, the government is considering holding its own clinical trials. Clinical trials for new drugs have so far primarily been conducted only by private Indian or foreign drug firms. But given the stringent nature of India's regulatory environment for clinical trials, several pharmaceutical companies have moved their trials out of India. As a result, only 1.2 per cent of global clinical trials take place in India.

How govt plans to buy med devices cheaply for Ayushman

How govt plans to buy med devices cheaply for Ayushman

Rediff.com   15 Dec 2019

According to a senior government official, the plan is to do "collective bargaining" for certain medical devices and implants by assuring a bulk requirement to the manufacturers. "The requirement for these devices runs into millions. We assure them that the requirement is going to be in bulk. In return, they should offer us better rates," he said.

Why prices of vitamin C, antibiotics could shoot up

Why prices of vitamin C, antibiotics could shoot up

Rediff.com   14 Dec 2019

The government said that "in exercise of extraordinary powers in public interest, conferred by paragraph 19 of the DPCO, 2013", the ceiling prices of 21 key formulations had been increased. These formulations include common medicines like BCG vaccines, penicillin, malaria and leprosy medicines (Dapsone), life-saving drugs like Furosemide (used to treat fluid build-up due to heart failure, liver scarring, or kidney disease), vitamin C, some common antibiotics, and anti-allergy medicines.

How BSNL plans to save Rs 7,500 crore

How BSNL plans to save Rs 7,500 crore

Rediff.com   29 Nov 2019

'BSNL employee cost is Rs 14,500 crore and we anticipate that around 80,000 should opt for VRS.'

Lupin sells Japan arm to Unison for Rs 3,702 cr

Lupin sells Japan arm to Unison for Rs 3,702 cr

Rediff.com   12 Nov 2019

The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India.

Online ticket sales a bonanza for multiplexes

Online ticket sales a bonanza for multiplexes

Rediff.com   31 Oct 2019

Revenue from convenience fees has grown at a compound annual rate of 85 per cent for multiplex chain operator Inox Leisure and 58 per cent for PVR.

BSNL, MTNL to spend Rs 11,000 cr on 4G infrastructure

BSNL, MTNL to spend Rs 11,000 cr on 4G infrastructure

Rediff.com   25 Oct 2019

The asset monetisation exercise in the first phase will help BSNL shave off its Rs 14,000-crore debt. The government has said that these firms are strategically important and will not be closed down or divested.

Both 5G spectrum and 700 MHz band auction may see few bidders

Both 5G spectrum and 700 MHz band auction may see few bidders

Rediff.com   15 Oct 2019

Analysts at rating agency ICRA say the debt level of the telecom companies is very high and the ecosystem for the premium band is not in place.

Amit Shah to inaugurate mobile congress on Monday

Amit Shah to inaugurate mobile congress on Monday

Rediff.com   13 Oct 2019

Home minister heads several groups of ministers, including the one to decide the revival package for Bharat Sanchar Nigam and Mahanagar Telephone Nigam. His ministry also takes decisive calls on national security in relation to telecom operations as well as equipment and technology used in the industry.

Govt may now cap prices of antibiotics

Govt may now cap prices of antibiotics

Rediff.com   7 Oct 2019

The intention of the government is to cap prices of drugs that are essential and which the public widely uses.

Demystifying the new Motor Vehicles Act

Demystifying the new Motor Vehicles Act

Rediff.com   28 Sep 2019

While some states have proposed to dilute the hefty penalty provisions in the Act, there are those like West Bengal which have refused to implement right away.

DRL, 1st Indian company to supply generic drugs to China's state hospitals

DRL, 1st Indian company to supply generic drugs to China's state hospitals

Rediff.com   27 Sep 2019

The drug that it would supply is called Olanzapine, used to treat schizophrenia and bipolar disorder.

GSK withdraws sale of Zinetac after health alert

GSK withdraws sale of Zinetac after health alert

Rediff.com   26 Sep 2019

GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.

With 5G spectrum shrinking, telcos may stay off auction

With 5G spectrum shrinking, telcos may stay off auction

Rediff.com   25 Sep 2019

It is learnt that the defence ministry is refusing to let go of its 100 MHz spectrum, which was allotted earlier. In that case, the department of telecommunications (DoT) will be left with only 175 MW of 5G spectrum of the total 300 MHz.

Hoping for a revival, BSNL staff pen their anguish to PM Modi

Hoping for a revival, BSNL staff pen their anguish to PM Modi

Rediff.com   24 Sep 2019

BSNL is providing telecom services in remote parts of the country and maintaining 17,000 to 18,000 exchanges, incurring Rs 3,000 to Rs 4,000 crore losses every year. Otherwise, these villages will be cut off.

Drones will deliver critical drugs at your doorstep

Drones will deliver critical drugs at your doorstep

Rediff.com   17 Sep 2019

Maharashtra govt, California-based Zipline to launch the automated delivery service funded by Serum Institute.